WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
238 days-252 days |
30 |
|
|
35.8 |
% |
5.4 |
29.58 |
ex vivo microscopy with digital image analysis |
0.0 |
lad occlusion |
196 |
days |
|
100264 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
266 days-280 days |
16 |
|
|
599.0 |
g |
35.0 |
140.0 |
body weighing method |
0.0 |
lad occlusion |
210 |
days |
|
100274 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
238 days-252 days |
30 |
|
|
0.97 |
g |
0.08 |
0.43 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100290 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
32 |
|
|
0.93 |
g |
0.1 |
0.54 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100293 |
2460 |
WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238 days-252 days |
7 |
|
|
10.6 |
ml/d |
2.2 |
5.82 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100376 |
2460 |
WKY |
kidney fibrotic lesion area to total kidney area ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney integrity trait |
male |
238 days-252 days |
15 |
|
|
0.48 |
% |
0.11 |
0.43 |
ex vivo light microscopy with histochemistry and digital image analysis |
0.0 |
lad occlusion |
196 |
days |
|
100384 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266 days-280 days |
32 |
|
|
8.8 |
mm |
0.3 |
1.7 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100311 |
2460 |
WKY |
left ventricular end-systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
67.5 |
mmHg |
3.9 |
22.06 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100323 |
2460 |
WKY |
maximum rate of positive change in left ventricular blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
2912.0 |
mmHg/s |
300.0 |
1200.0 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100328 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
|
|
10.6 |
mm |
0.2 |
0.89 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100340 |
2460 |
WKY |
heart posterior wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238 days-252 days |
20 |
|
|
0.17 |
cm |
0.01 |
0.04 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100346 |
2460 |
WKY |
heart posterior wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle posterior wall thickness |
male |
238 days-252 days |
30 |
|
|
0.18 |
cm |
0.0 |
0.02 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100347 |
2460 |
WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238 days-252 days |
7 |
|
|
11.4 |
ml/d |
2.4 |
6.35 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100361 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
238 days-252 days |
30 |
|
|
1.57 |
g |
0.28 |
1.53 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100278 |
2460 |
WKY |
heart weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
32 |
|
|
0.31 |
g/cm |
0.04 |
0.23 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100284 |
2460 |
WKY |
heart rate |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266 days-280 days |
16 |
|
|
362.0 |
beats/min |
31.0 |
124.0 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100313 |
2460 |
WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
238 days-252 days |
20 |
|
|
35.2 |
% |
4.5 |
20.12 |
ex vivo microscopy with digital image analysis |
0.0 |
lad occlusion |
196 |
days |
|
100263 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion then vehicle control condition |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
42 days-56 days |
30 |
|
|
225.0 |
g |
1.8 |
9.86 |
body weighing method |
0.0 |
lad occlusion |
0 |
days |
|
100269 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
238 days-252 days |
20 |
|
|
583.0 |
g |
56.0 |
250.44 |
body weighing method |
0.0 |
lad occlusion |
196 |
days |
|
100271 |
2460 |
WKY |
heart left ventricle weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
32 |
|
|
0.21 |
g/cm |
0.02 |
0.11 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100296 |
2460 |
WKY |
lung wet weight |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
lung mass |
male |
238 days-252 days |
30 |
|
|
2.13 |
g |
0.13 |
0.71 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100299 |
2460 |
WKY |
artery tunica media width to artery inner diameter ratio |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney blood vessel morphology trait |
male |
238 days-252 days |
15 |
|
|
1.82 |
null |
0.15 |
0.58 |
ex vivo light microscopy with histochemistry and digital image analysis |
0.0 |
lad occlusion |
196 |
days |
|
100388 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
|
|
18.0 |
% |
1.5 |
8.49 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100305 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
|
|
10.8 |
mm |
0.3 |
1.2 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100307 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
266 days-280 days |
16 |
|
|
9.1 |
mm |
0.4 |
1.6 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100310 |
2460 |
WKY |
heart rate |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart pumping trait |
male |
266 days-280 days |
32 |
|
|
373.0 |
beats/min |
15.0 |
84.85 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100314 |
2460 |
WKY |
left ventricular end-diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
5.96 |
mmHg |
0.84 |
4.75 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100326 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238 days-252 days |
20 |
|
|
35.5 |
% |
2.0 |
8.94 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100352 |
2460 |
WKY |
right kidney wet weight |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238 days-252 days |
15 |
|
|
1.35 |
g |
0.04 |
0.17 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100359 |
2460 |
WKY |
plasma creatinine level |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238 days-252 days |
6 |
|
|
0.52 |
mg/dl |
0.04 |
0.1 |
plasma creatinine analysis |
0.0 |
lad occlusion |
196 |
days |
|
100365 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
238 days-252 days |
30 |
|
|
617.0 |
g |
52.0 |
284.82 |
body weighing method |
0.0 |
lad occlusion |
196 |
days |
|
100272 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
238 days-252 days |
20 |
|
|
0.96 |
g |
0.12 |
0.53 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100289 |
2460 |
WKY |
maximum rate of positive change in left ventricular blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
2882.0 |
mmHg/s |
208.0 |
1176.63 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100329 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion then furosemide |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
42 days-56 days |
20 |
|
|
225.0 |
g |
3.0 |
13.42 |
body weighing method |
0.0 |
lad occlusion |
0 |
days |
|
100268 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
16 |
|
|
1.88 |
g |
0.61 |
2.42 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100280 |
2460 |
WKY |
right kidney wet weight |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238 days-252 days |
15 |
|
|
1.35 |
g |
0.04 |
0.17 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100373 |
2460 |
WKY |
plasma creatinine level |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238 days-252 days |
6 |
|
|
0.52 |
mg/dl |
0.04 |
0.1 |
plasma creatinine analysis |
0.0 |
lad occlusion |
196 |
days |
|
100379 |
2460 |
WKY |
diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
47.6 |
mmHg |
2.7 |
15.27 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100320 |
2460 |
WKY |
serum sodium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood sodium amount |
male |
266 days-280 days |
16 |
|
|
153.5 |
mmol/l |
2.1 |
8.4 |
automated serum sodium test |
0.0 |
lad occlusion |
210 |
days |
|
100331 |
2460 |
WKY |
heart ventricle septal wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238 days-252 days |
20 |
|
|
0.13 |
cm |
0.03 |
0.13 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100337 |
2460 |
WKY |
E/A wave ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238 days-252 days |
20 |
|
|
1.61 |
null |
0.21 |
0.94 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100355 |
2460 |
WKY |
right kidney wet weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238 days-252 days |
15 |
|
|
1.37 |
g |
0.04 |
0.14 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100358 |
2460 |
WKY |
E/A wave ratio |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood flow trait |
male |
238 days-252 days |
30 |
|
|
1.85 |
null |
0.14 |
0.77 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100356 |
2460 |
WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238 days-252 days |
7 |
|
|
10.6 |
ml/d |
2.2 |
5.82 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100362 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
32 |
|
|
1.44 |
g |
0.37 |
2.09 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100281 |
2460 |
WKY |
heart left ventricle weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
16 |
|
|
0.24 |
g/cm |
0.03 |
0.12 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
lv/tl |
100295 |
2460 |
WKY |
timed urine volume |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
urine output |
male |
238 days-252 days |
7 |
|
|
11.4 |
ml/d |
2.4 |
6.35 |
urine volume measurement method |
0.0 |
lad occlusion |
196 |
days |
|
100375 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
30 |
|
|
10.6 |
mm |
0.1 |
0.55 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100341 |
2460 |
WKY |
right kidney wet weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney mass |
male |
238 days-252 days |
15 |
|
|
1.37 |
g |
0.04 |
0.14 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100372 |
2460 |
WKY |
heart weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
238 days-252 days |
20 |
|
|
1.56 |
g |
0.42 |
1.86 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100277 |
2460 |
WKY |
kidney fibrotic lesion area to total kidney area ratio |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney integrity trait |
male |
238 days-252 days |
15 |
|
|
0.75 |
% |
0.13 |
0.5 |
ex vivo light microscopy with histochemistry and digital image analysis |
0.0 |
lad occlusion |
196 |
days |
|
100385 |
2460 |
WKY |
artery tunica media width to artery inner diameter ratio |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
kidney blood vessel morphology trait |
male |
238 days-252 days |
15 |
|
|
1.56 |
null |
0.1 |
0.39 |
ex vivo light microscopy with histochemistry and digital image analysis |
0.0 |
lad occlusion |
196 |
days |
|
100387 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
16 |
|
|
16.8 |
% |
1.6 |
6.4 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100304 |
2460 |
WKY |
systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
79.5 |
mmHg |
5.1 |
20.4 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100316 |
2460 |
WKY |
left ventricular end-systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
73.5 |
mmHg |
4.7 |
18.8 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100322 |
2460 |
WKY |
left ventricular end-diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricular blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
9.36 |
mmHg |
1.62 |
6.48 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100325 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238 days-252 days |
20 |
|
|
9.0 |
mm |
0.2 |
0.89 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100343 |
2460 |
WKY |
heart left ventricle end-systolic diameter |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-systolic diameter |
male |
238 days-252 days |
30 |
|
|
8.9 |
mm |
0.2 |
1.1 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100344 |
2460 |
WKY |
plasma creatinine level |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238 days-252 days |
6 |
|
|
0.47 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
0.0 |
lad occlusion |
196 |
days |
|
100364 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
30 |
|
|
15.8 |
% |
0.7 |
3.83 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100350 |
2460 |
WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
266 days-280 days |
16 |
|
|
31.8 |
% |
10.1 |
40.4 |
ex vivo microscopy with digital image analysis |
0.0 |
lad occlusion |
210 |
days |
|
100265 |
2460 |
WKY |
body weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
body mass |
male |
266 days-280 days |
32 |
|
|
574.0 |
g |
38.0 |
214.96 |
body weighing method |
0.0 |
lad occlusion |
210 |
days |
|
100275 |
2460 |
WKY |
tibia length |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
tibia length |
male |
266 days-280 days |
16 |
|
|
4.3 |
cm |
0.09 |
0.36 |
post excision length measurement |
0.0 |
lad occlusion |
210 |
days |
|
100286 |
2460 |
WKY |
heart left ventricle weight |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle mass |
male |
266 days-280 days |
16 |
|
|
1.04 |
g |
0.13 |
0.51 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100292 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266 days-280 days |
16 |
|
|
38.5 |
% |
3.2 |
12.8 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100301 |
2460 |
WKY |
heart left ventricle end-diastolic diameter |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
266 days-280 days |
32 |
|
|
10.6 |
mm |
0.3 |
1.7 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100308 |
2460 |
WKY |
serum potassium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood potassium amount |
male |
266 days-280 days |
32 |
|
|
4.9 |
mmol/l |
0.1 |
0.57 |
automated serum potassium test |
0.0 |
lad occlusion |
210 |
days |
|
100335 |
2460 |
WKY |
heart left ventricle infarction size to total heart left ventricle size ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle integrity trait |
male |
266 days-280 days |
32 |
|
|
30.9 |
% |
8.1 |
45.82 |
ex vivo microscopy with digital image analysis |
0.0 |
lad occlusion |
210 |
days |
|
100266 |
2460 |
WKY |
heart weight to tibia length ratio |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart mass |
male |
266 days-280 days |
16 |
|
|
0.4 |
g/cm |
0.1 |
0.4 |
post excision weight measurement |
0.0 |
lad occlusion |
210 |
days |
|
100283 |
2460 |
WKY |
tibia length |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
tibia length |
male |
266 days-280 days |
32 |
|
|
4.3 |
cm |
0.09 |
0.51 |
post excision length measurement |
0.0 |
lad occlusion |
210 |
days |
|
100287 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
266 days-280 days |
32 |
|
|
40.5 |
% |
2.4 |
13.58 |
echocardiography |
0.0 |
lad occlusion |
210 |
days |
|
100302 |
2460 |
WKY |
systolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
32 |
10 min mean |
continuous mean |
75.1 |
mmHg |
2.4 |
13.58 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100317 |
2460 |
WKY |
diastolic blood pressure |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ketamine (80 mg/kg) then xylazine (10 mg/kg) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
arterial blood pressure trait |
male |
266 days-280 days |
16 |
10 min mean |
continuous mean |
53.0 |
mmHg |
5.2 |
20.8 |
vascular transducer tipped catheter |
0.0 |
lad occlusion |
210 |
days |
|
100319 |
2460 |
WKY |
serum potassium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood potassium amount |
male |
266 days-280 days |
16 |
|
|
5.0 |
mmol/l |
0.19 |
0.76 |
automated serum potassium test |
0.0 |
lad occlusion |
210 |
days |
|
100334 |
2460 |
WKY |
heart left ventricle fractional shortening |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle end-diastolic diameter |
male |
238 days-252 days |
20 |
|
|
15.1 |
% |
1.0 |
4.47 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100349 |
2460 |
WKY |
ejection fraction |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
cardiac output trait |
male |
238 days-252 days |
30 |
|
|
37.0 |
% |
1.4 |
7.67 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100353 |
2460 |
WKY |
lung wet weight |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
lung mass |
male |
238 days-252 days |
20 |
|
|
2.24 |
g |
0.19 |
0.85 |
post excision weight measurement |
0.0 |
lad occlusion |
196 |
days |
|
100298 |
2460 |
WKY |
plasma creatinine level |
left anterior descending coronary artery occlusion (for 196 days) then furosemide (10 ml/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood creatinine amount |
male |
238 days-252 days |
6 |
|
|
0.47 |
mg/dl |
0.03 |
0.07 |
plasma creatinine analysis |
0.0 |
lad occlusion |
196 |
days |
|
100378 |
2460 |
WKY |
serum sodium level |
left anterior descending coronary artery occlusion (for 224 days) then furosemide (10 mg/kg/d) (for 161 days) then ramipril (1 mg/kg/d) (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
blood sodium amount |
male |
266 days-280 days |
32 |
|
|
155.1 |
mmol/l |
1.1 |
6.22 |
automated serum sodium test |
0.0 |
lad occlusion |
210 |
days |
|
100332 |
2460 |
WKY |
heart ventricle septal wall thickness |
left anterior descending coronary artery occlusion (for 196 days) then vehicle control condition (for 182 days) |
Rokutan H, et al., Int J Cardiol. 2012 Sep 20;160(1):20-5. doi: 10.1016/j.ijcard.2011.03.005. Epub 2011 Mar 29. |
heart left ventricle wall thickness |
male |
238 days-252 days |
30 |
|
|
0.1 |
cm |
0.0 |
0.02 |
echocardiography |
0.0 |
lad occlusion |
196 |
days |
|
100338 |
2460 |